Skip Page Banner  
INTELLECTUAL PROPERTY
BLOG

Monday, April 8, 2013

Novartis Loses Patent Appeal for Cancer Medication Glivec

by Bloomberg BNA correspondent

RSS

Bloomberg BNA full story: 

BNA's correspondent in India, Madhur Singh, provided this writeup of the decision by India's top court rejecting Novartis's appeal seeking grant of a patent for its cancer drug Glivec, appearing in BNA's Patent, Trademark & Copyright Law Daily (accessible to both subscribers and non-subscribers).
Subscription RequiredAll BNA publications are subscription-based and require an account. If you are a subscriber to the BNA publication and signed-in, you will automatically have access to the story. If you are not a subscriber, you will need to sign-up for a trial subscription.

You must Sign In or Register to post a comment.

Comments (0)